Abbott Laboratories snagged a CE mark for its Volt pulsed field ablation catheter for atrial fibrillation several months earlier than the mid-year approval expected. The Abbott Park, Ill.-based company has begun Volt’s commercial launch with the physicians who participated in its European clinical trials and plans to expand to other users on the continent in the second half of 2025. Read More
The U.S. Department of Health and Human Services HHS reported a plan to reduce staffing by 10,000 in an immediate reduction, which when paired with retirement initiatives will drop staffing by as many as 20,000. Read More
The U.S. FDA gave the green light to Nanosonics Ltd.’s Coris system via de novo clearance for reducing infection risk by delivering improved cleaning outcomes for flexible endoscopes, especially the complex channels of endoscopes that are prone to biofilm build up. Read More
Scientists in the U.K. have developed a new meta-material, dubbed Roliner, to improve the fitting of wearable devices made from hard materials, such as prosthetic limbs. Read More
Acrivon Therapeutics Inc. provided updated phase II data for checkpoint kinase candidate ACR-368, highlighting promising response rates for biomarker-positive patients with endometrial cancer and raising the possibility of an accelerated pathway in the second-line setting. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alcon, Aurion Biotech, Cytosite, Eyedeal Medical, GE Healthcare, Lantheus, Pantheon Vision, Vivani Medical. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: 4Moving, Abbott Labs, MedCAD, Restor3d, Vasorum. Read More
